Global Tourette Syndrome Drug Market By Product Type (AZD-5213, CPP-115) And By End-Users/Application (Research Center, Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985474
  • April 2021
  • Pharmaceuticals
  • 113 Pages

Report Preview

The Tourette Syndrome Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Tourette Syndrome Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Tourette Syndrome Drug market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Tourette Syndrome Drug market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Tourette Syndrome Drug market along with their effects over the forecast period. Similarly, according to the region Tourette Syndrome Drug market research report includes the study of opportunities available in the market situation.

The Tourette Syndrome Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, Others
Applications Research Center, Hospital, Clinic, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, Teva Pharmaceutical Industries Ltd, Therapix Biosciences Ltd

Global Tourette Syndrome Drug Market Segmentation by Regions:
In regional analysis, Tourette Syndrome Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Tourette Syndrome Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Tourette Syndrome Drug Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Tourette Syndrome Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Tourette Syndrome Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Tourette Syndrome Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Tourette Syndrome Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Tourette Syndrome Drug Market Segmentation by Type:
On the basis of product type, global Tourette Syndrome Drug market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: AZD-5213, CPP-115, Dutetrabenazine ER, Ecopipam Hydrochloride, Others

Global Tourette Syndrome Drug Market Segmentation by Applications:
On the basis of the end users/applications, Tourette Syndrome Drug research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Research Center, Hospital, Clinic, Others

Major Key Players for Global Tourette Syndrome Drug Market:
The Tourette Syndrome Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, Teva Pharmaceutical Industries Ltd, Therapix Biosciences Ltd

Important Points Covered by Report:
  • To analyze the value of the Tourette Syndrome Drug market, according to the key region.
  • To study the Tourette Syndrome Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Tourette Syndrome Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Tourette Syndrome Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Tourette Syndrome Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Tourette Syndrome Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Tourette Syndrome Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Tourette Syndrome Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Tourette Syndrome Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Tourette Syndrome Drug Market Snapshot
          2.1.1. Global Tourette Syndrome Drug Market By Type,2019
               2.1.1.1.AZD-5213
               2.1.1.2.CPP-115
               2.1.1.3.Dutetrabenazine ER
               2.1.1.4.Ecopipam Hydrochloride
               2.1.1.5.Others
          2.1.2. Global Tourette Syndrome Drug Market By Application,2019
               2.1.2.1.Research Center
               2.1.2.2.Hospital
               2.1.2.3.Clinic
               2.1.2.4.Others
          2.1.3. Global Tourette Syndrome Drug Market By End-use,2019
          2.1.4. Global Tourette Syndrome Drug Market By Geography,2019

3. Global Tourette Syndrome Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028

5. Global Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028

6. Global Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Tourette Syndrome Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Tourette Syndrome Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Tourette Syndrome Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Tourette Syndrome Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Tourette Syndrome Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Tourette Syndrome Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Tourette Syndrome Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Tourette Syndrome Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Tourette Syndrome Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Tourette Syndrome Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Tourette Syndrome Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Tourette Syndrome Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Tourette Syndrome Drug Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Tourette Syndrome Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Tourette Syndrome Drug Providers
        8.4.1 Abide Therapeutics Inc
                8.1.1 Business Description
                8.1.2 Abide Therapeutics Inc Geographic Operations
                8.1.3 Abide Therapeutics Inc Financial Information
                8.1.4 Abide Therapeutics Inc Product Positions/Portfolio
                8.1.5 Abide Therapeutics Inc Key Developments
        8.4.2 Catalyst Pharmaceuticals Inc
                8.2.1 Business Description
                8.2.2 Catalyst Pharmaceuticals Inc Geographic Operations
                8.2.3 Catalyst Pharmaceuticals Inc Financial Information
                8.2.4 Catalyst Pharmaceuticals Inc Product Positions/Portfolio
                8.2.5 Catalyst Pharmaceuticals Inc Key Developments
        8.4.3 Neurocrine Biosciences Inc
                8.3.1 Business Description
                8.3.2 Neurocrine Biosciences Inc Geographic Operations
                8.3.3 Neurocrine Biosciences Inc Financial Information
                8.3.4 Neurocrine Biosciences Inc Product Positions/Portfolio
                8.3.5 Neurocrine Biosciences Inc Key Developments
        8.4.4 Psyadon Pharmaceuticals Inc
                8.4.1 Business Description
                8.4.2 Psyadon Pharmaceuticals Inc Geographic Operations
                8.4.3 Psyadon Pharmaceuticals Inc Financial Information
                8.4.4 Psyadon Pharmaceuticals Inc Product Positions/Portfolio
                8.4.5 Psyadon Pharmaceuticals Inc Key Developments
        8.4.5 Reviva Pharmaceuticals Inc
                8.5.1 Business Description
                8.5.2 Reviva Pharmaceuticals Inc Geographic Operations
                8.5.3 Reviva Pharmaceuticals Inc Financial Information
                8.5.4 Reviva Pharmaceuticals Inc Product Positions/Portfolio
                8.5.5 Reviva Pharmaceuticals Inc Key Developments
        8.4.6 Synchroneuron Inc
                8.6.1 Business Description
                8.6.2 Synchroneuron Inc Geographic Operations
                8.6.3 Synchroneuron Inc Financial Information
                8.6.4 Synchroneuron Inc Product Positions/Portfolio
                8.6.5 Synchroneuron Inc Key Developments
        8.4.7 Teva Pharmaceutical Industries Ltd
                8.7.1 Business Description
                8.7.2 Teva Pharmaceutical Industries Ltd Geographic Operations
                8.7.3 Teva Pharmaceutical Industries Ltd Financial Information
                8.7.4 Teva Pharmaceutical Industries Ltd Product Positions/Portfolio
                8.7.5 Teva Pharmaceutical Industries Ltd Key Developments
        8.4.8 Therapix Biosciences Ltd
                8.8.1 Business Description
                8.8.2 Therapix Biosciences Ltd Geographic Operations
                8.8.3 Therapix Biosciences Ltd Financial Information
                8.8.4 Therapix Biosciences Ltd Product Positions/Portfolio
                8.8.5 Therapix Biosciences Ltd Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Tourette Syndrome Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Tourette Syndrome Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Tourette Syndrome Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Tourette Syndrome Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Tourette Syndrome Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Tourette Syndrome Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Tourette Syndrome Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Tourette Syndrome Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Tourette Syndrome Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Tourette Syndrome Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Tourette Syndrome Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Tourette Syndrome Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Tourette Syndrome Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Tourette Syndrome Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Tourette Syndrome Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Tourette Syndrome Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Tourette Syndrome Drug: Market Segmentation 
FIG. 2 Global Tourette Syndrome Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Tourette Syndrome Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Tourette Syndrome Drug Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Tourette Syndrome Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Tourette Syndrome Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Tourette Syndrome Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Tourette Syndrome Drug Providers, 2019
FIG. 11 Global Tourette Syndrome Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Tourette Syndrome Drug Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Tourette Syndrome Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Tourette Syndrome Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Tourette Syndrome Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Tourette Syndrome Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Tourette Syndrome Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Tourette Syndrome Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Tourette Syndrome Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Tourette Syndrome Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Tourette Syndrome Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Tourette Syndrome Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Tourette Syndrome Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Tourette Syndrome Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Tourette Syndrome Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Tourette Syndrome Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Tourette Syndrome Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Tourette Syndrome Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Tourette Syndrome Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Tourette Syndrome Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Tourette Syndrome Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Tourette Syndrome Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Tourette Syndrome Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Tourette Syndrome Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Tourette Syndrome Drug Market Value, By Country, 2018 – 2028
TABLE  Abide Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Catalyst Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Neurocrine Biosciences Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Psyadon Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Reviva Pharmaceuticals Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Synchroneuron Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Therapix Biosciences Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Tourette Syndrome Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Tourette Syndrome Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Tourette Syndrome Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Tourette Syndrome Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Tourette Syndrome Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Tourette Syndrome Drug Providers, 2016
FIG.  Global Tourette Syndrome Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global AZD-5213 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CPP-115 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Dutetrabenazine ER Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ecopipam Hydrochloride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tourette Syndrome Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Research Center Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Tourette Syndrome Drug Market Value, 2018 – 2028, (US$ Mn)